How the Veterinary Diagnostics Market is Transforming Animal Healthcare

코멘트 · 6 견해

Neogen Corporation (US) launched Igenity BCHF, a test to detect an animal’s genetic predisposition for Bovine Congestive Heart Failure (BCHF). It will help improve bovine heart health standards.

The veterinary diagnostics market is projected to grow from USD 3.68 billion in 2025 to USD 5.36 billion by 2030, registering a CAGR of 7.8%. This robust growth reflects rising awareness of diagnostic testing for companion animals, increasing production and consumption of livestock, and supportive government initiatives aimed at improving animal health. Advancements in diagnostic instruments, analyzers, and point-of-care (POC) testing solutions are transforming animal healthcare delivery worldwide.

Download PDF Brochure

Key Growth Drivers

  1. Rising Pet Ownership and Companion Animal Care

The companion animals segment held the largest market share in 2024, driven by the growing number of households owning pets such as dogs and cats.

  • Increased Pet Health Awareness: Owners are more willing to spend on preventive diagnostics and advanced treatments.
  • Technological Access: Availability of rapid diagnostic kits supports faster, more accurate decision-making.
  1. Growth in Livestock Health Testing

With increasing demand for meat, dairy, and other animal-based products, livestock health monitoring is crucial to ensure food safety, productivity, and zoonotic disease control. Government-led disease surveillance programs are accelerating adoption of veterinary diagnostics in farms.

  1. Technological Advancements and POC Testing

The POC/in-house testing segment is forecasted to grow at the highest CAGR, enabling faster diagnosis at veterinary clinics and even on farms.

  • Near-Patient Testing: POC solutions reduce turnaround time and support immediate treatment decisions.
  • Innovative Tools: Cartridge-based analyzers and AI-enabled devices are making high-quality testing more accessible.
  1. Regional Growth Opportunities
  • North America: Dominates the market in 2024 due to high pet insurance penetration, frequent veterinary visits, and strong presence of leading players.
  • Asia Pacific: Expected to register the fastest CAGR through 2030, driven by urbanization, rising disposable incomes, pet adoption rates, and expanded veterinary infrastructure. Countries like China and India are investing heavily in animal health R&D and disease surveillance programs.

Competitive Landscape

The market remains moderately consolidated, with leading players focusing on innovation, portfolio expansion, and geographic reach.

Key Players

  • IDEXX Laboratories, Inc. (US): Market leader with a strong portfolio of in-clinic diagnostic analyzers and test kits.
  • Zoetis Services LLC (US): Innovator in cartridge-based AI-driven CBC testing (Vetscan OptiCell).
  • Thermo Fisher Scientific Inc. (US): Offers a wide range of molecular and immunodiagnostic solutions.
  • Antech Diagnostics, Inc. (US): Strengthened portfolio with launch of truRapid FOUR, enabling faster in-house screening for canine vector-borne diseases.
  • bioMérieux (France): Recently introduced VETFIRE, a PCR kit for simultaneous detection of seven equine infectious respiratory pathogens.

Recent Market Developments (2024–2025)

  • June 2025: bioMérieux launched VETFIRE, a ready-to-use PCR kit for equine infectious respiratory diseases.
  • March 2025: Antech Diagnostics released truRapid FOUR, a lateral flow test for rapid in-house CVBD screening.
  • January 2025: Neogen Corporation introduced Igenity BCHF, a genetic test for Bovine Congestive Heart Failure predisposition.
  • December 2024: Zoetis launched Vetscan OptiCell, an AI-enabled cartridge-based CBC analyzer for veterinary clinics.

Request Sample Report

Strategic Insights for Stakeholders

For C-level executives, investors, and product strategists, the veterinary diagnostics market offers several opportunities:

  • Invest in POC Testing Solutions: High CAGR and market demand for faster diagnosis make this a key growth area.
  • Expand in APAC & Emerging Economies: Rising pet adoption and government-led livestock health initiatives present strong market entry points.
  • Leverage AI and Automation: AI-driven diagnostics and data integration can boost decision-making and improve treatment outcomes.
  • Partnerships & M&A: Collaborations with local distributors and veterinary clinics can accelerate market penetration.

Outlook

The veterinary diagnostics market is on a growth trajectory fueled by technological innovation, shifting pet ownership dynamics, and rising livestock health priorities. Players who focus on R&D investments, geographic diversification, and value-added services are well-positioned to capture market share in the coming decade.

코멘트